Tag:
Helsinn
Latest Headlines
Latest Headlines
Zealand Pharma inks $177M pact for early-stage compound
Denmark's Zealand Pharma has licensed out the worldwide rights--outside of the Nordic countries--to an early-stage compound targeting chemotherapy-induced diarrhea. Helsinn gained the marketing
